News 2024 - Forschungszentrum Borstel, Leibniz Lungenzentrum

16.12.2024

Consensus on the management of tuberculosis in migrants

Global migration has increased in recent decades due to war, conflict, persecutions, and natural disasters, but also secondary to increased opportunities related to work or study. Tuberculosis is a preventable and treatable infectious disease and the leading cause of death in infections worldwide. A group of international experts that collaborate in the Tuberculosis Network European Trialsgroup (TBnet; www.tbnet.eu) has now identified the risk for tuberculosis and comorbidities in migrants to the European Union/European Economic Area and the United Kingdom (EU/EEA&UK).

Der Sonderpreis der Jury geht an Prof. Dr. Andra Schromm (Foto: Guido Kollmeier / Universität zu Lübeck)

15.12.2024

Good scientific practice - from KODEX to science

Prof. Andra Schromm receives special teaching award for her innovative learning concept

11.12.2024

Very British: Fellow of the Royal College of Physicians

Professor Christoph Lange, Medical Director of the Research Center Borstel, Leibniz Lung Center, was elected as a “Fellow” by the Council of the Royal College of Physicians in London, UK, together with 6 other doctors from Europe this year.

04.12.2024

Infections with antibiotic resistant Haemophilus influenzae bacteria

New study highlights challenges in the detection of ampicillin resistant infections with Haemophilus influenzae

01.12.2024

Self-administered outpatient intravenous therapy of drug-resistant tuberculosis

Borstel researchers show: Self-administered outpatient intravenous antimicrobial therapy in drug-resistant TB is effective and safe.

Page 1 of 8